Alfentanil
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00802 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 76 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 2 | migraine disorder | KG + DL |
| 3 | hypertrichosis (disease) | KG + DL |
| 4 | migraine with brainstem aura | KG + DL |
| 5 | syndrome with a Dandy-Walker malformation as major feature | KG + DL |
| 6 | malformation syndrome with odontal and/or periodontal component | KG + DL |
| 7 | Ambras type hypertrichosis universalis congenita | KG + DL |
| 8 | isolated genetic hair shaft abnormality | KG + DL |
| 9 | headache disorder | KG + DL |
| 10 | leprosy | KG + DL |
| 11 | common cold | KG + DL |
| 12 | trigeminal autonomic cephalalgia | KG + DL |
| 13 | tendinitis | KG + DL |
| 14 | myositis fibrosa | KG + DL |
| 15 | idiopathic granulomatous myositis | KG + DL |
| 16 | motor nerve neuritis | KG + DL |
| 17 | vestibular neuronitis | KG + DL |
| 18 | fibromyalgia | KG + DL |
| 19 | brachial plexus neuritis | KG + DL |
| 20 | pneumocystosis | KG + DL |
| 21 | Plasmodium falciparum malaria | KG + DL |
| 22 | neuroretinitis | KG + DL |
| 23 | allergic urticaria | KG + DL |
| 24 | Cryptococcal meningitis | KG + DL |
| 25 | inclusion body myositis | KG + DL |
| 26 | migraine with or without aura, susceptibility to | KG + DL |
| 27 | atrophoderma vermiculata | KG + DL |
| 28 | uterine polyp | KG + DL |
| 29 | polyp of vocal cord | KG + DL |
| 30 | epulis | KG + DL |
| 31 | polyp of middle ear | KG + DL |
| 32 | fibroepithelial polyp | KG + DL |
| 33 | polyp of frontal sinus | KG + DL |
| 34 | polyp of ureter | KG + DL |
| 35 | polyp of external auditory canal | KG + DL |
| 36 | neoplastic polyp | KG + DL |
| 37 | polyp of vulva | KG + DL |
| 38 | subarachnoid hemorrhage (disease) | KG + DL |
| 39 | renin-angiotensin-aldosterone system-blocker-induced angioedema | KG + DL |
| 40 | nephrogenic diabetes insipidus | KG + DL |
| 41 | cold urticaria | KG + DL |
| 42 | angioedema | KG + DL |
| 43 | ulerythema ophryogenesis | KG + DL |
| 44 | Prinzmetal angina | KG + DL |
| 45 | dysthymic disorder | KG + DL |
| 46 | papillary conjunctivitis | KG + DL |
| 47 | persistent Mullerian duct syndrome | KG + DL |
| 48 | oral candidiasis | KG + DL |
| 49 | enterobiasis | KG + DL |
| 50 | nephrogenic diabetes insipidus-intracranial calcification syndrome | KG + DL |
(Showing top 50 of 76 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.